Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Hill-McManus

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Pharmacoeconomics|August 21, 2023
The Difference Method Approach for Sampling Order Constrained Parameters: An Improved Implementation and Important LimitationsDaniel Hill-McManus
CPT: Pharmacometrics & Systems Pharmacology|December 14, 2020
Combining Model-Based Clinical Trial Simulation, Pharmacoeconomics, and Value of Information to Optimize Trial DesignDaniel Hill-McManus, Dyfrig A Hughes
British Journal of Clinical Pharmacology|December 16, 2021
Choice of oral anticoagulant prescribed by general practices in Wales: Application of Dirichlet regression and linked dataDaniel Hill-McManus, Dyfrig A Hughes
Clinical Pharmacology and Therapeutics|April 18, 2019
Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for GoutDaniel Hill-McManus, Scott Marshall, Elena Soto, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 4, 2018
Impact of Non-Adherence and Flare Resolution on the Cost-Effectiveness of Treatments for Gout: Application of a Linked Pharmacometric/Pharmacoeconomic ModelDaniel Hill-McManus, Scott Marshall, Elena Soto, et al.
British Journal of Clinical Pharmacology|September 10, 2017
Impact of non-adherence on the safety and efficacy of uric acid-lowering therapies in the treatment of goutDaniel Hill-McManus, Elena Soto, Scott Marshall, et al.
Addiction (Abingdon, England)|August 15, 2013
Trend analysis and modelling of gender-specific age, period and birth cohort effects on alcohol abstention and consumption level for drinkers in Great Britain using the General Lifestyle Survey 1984-2009Yang Meng, John Holmes, Daniel Hill-McManus, et al.
BMJ (Clinical Research Ed.)|October 2, 2014
Potential benefits of minimum unit pricing for alcohol versus a ban on below cost selling in England 2014: modelling studyAlan Brennan, Yang Meng, John Holmes, et al.
Clinical Pharmacology and Therapeutics|September 16, 2020
Linked Pharmacometric-Pharmacoeconomic Modeling and Simulation in Clinical Drug DevelopmentDaniel Hill-McManus, Scott Marshall, Jing Liu, et al.
Drug and Alcohol Dependence|October 17, 2013
Estimation of usual occasion-based individual drinking patterns using diary survey dataDaniel Hill-McManus, Colin Angus, Yang Meng, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Pharmacoeconomics|August 21, 2023
The Difference Method Approach for Sampling Order Constrained Parameters: An Improved Implementation and Important LimitationsDaniel Hill-McManus
CPT: Pharmacometrics & Systems Pharmacology|December 14, 2020
Combining Model-Based Clinical Trial Simulation, Pharmacoeconomics, and Value of Information to Optimize Trial DesignDaniel Hill-McManus, Dyfrig A Hughes
British Journal of Clinical Pharmacology|December 16, 2021
Choice of oral anticoagulant prescribed by general practices in Wales: Application of Dirichlet regression and linked dataDaniel Hill-McManus, Dyfrig A Hughes
Clinical Pharmacology and Therapeutics|April 18, 2019
Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for GoutDaniel Hill-McManus, Scott Marshall, Elena Soto, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 4, 2018
Impact of Non-Adherence and Flare Resolution on the Cost-Effectiveness of Treatments for Gout: Application of a Linked Pharmacometric/Pharmacoeconomic ModelDaniel Hill-McManus, Scott Marshall, Elena Soto, et al.
British Journal of Clinical Pharmacology|September 10, 2017
Impact of non-adherence on the safety and efficacy of uric acid-lowering therapies in the treatment of goutDaniel Hill-McManus, Elena Soto, Scott Marshall, et al.
Addiction (Abingdon, England)|August 15, 2013
Trend analysis and modelling of gender-specific age, period and birth cohort effects on alcohol abstention and consumption level for drinkers in Great Britain using the General Lifestyle Survey 1984-2009Yang Meng, John Holmes, Daniel Hill-McManus, et al.
BMJ (Clinical Research Ed.)|October 2, 2014
Potential benefits of minimum unit pricing for alcohol versus a ban on below cost selling in England 2014: modelling studyAlan Brennan, Yang Meng, John Holmes, et al.
Clinical Pharmacology and Therapeutics|September 16, 2020
Linked Pharmacometric-Pharmacoeconomic Modeling and Simulation in Clinical Drug DevelopmentDaniel Hill-McManus, Scott Marshall, Jing Liu, et al.
Drug and Alcohol Dependence|October 17, 2013
Estimation of usual occasion-based individual drinking patterns using diary survey dataDaniel Hill-McManus, Colin Angus, Yang Meng, et al.
Pageof 3